Head-to-head · free

MOGU Inc. vs The Precision Peptide Company

MOGU vs PNGAF — return on capital, cash generation, margins and balance sheet side by side.

MOGU

0 / 0

measures where MOGU leads

PNGAF

0 / 0

measures where PNGAF leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureMOGUPNGAF
Revenue——
Net income——
Revenue growth (yearly, multi-year)——
Free cash flow——
Free cash flow margin——
Net cash / (debt)——
ROIC1.7%—
Return on equity0.4%—
Gross margin28.6%—
Operating margin-58.5%—
Net debt / EBITDA2.22x—

Figures are as reported by each company; latest fiscal year shown.

Where MOGU Inc.'s cash went

Not reported yet.

Full MOGU profile →

Where The Precision Peptide Company's cash went

Not reported yet.

Full PNGAF profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons